MacroGenics, Inc.
MacroGenics, Inc. logo
MGNX

MacroGenics, Inc. (MGNX)

$6.387.54%

Market is closed
– opens on 8 PM, 06 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$6.2
Day's Range
$6.82
$2.13
52-Week Range
$17.94
1 month return0.62%
3 month return57.14%
1 year return61.86%
5 year return66.51%

Company Information

MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
OrganizationMacroGenics, Inc.
Employees427
CEODr. Scott Koenig M.D., Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
90%
Buy
9%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for MacroGenics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 78.68%

Current

$6.38

Target

$11.4

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
10
13
14
Hold
1
4
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
424.2M
Book Value
$2.0
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-3.56
PEG Ratio
0.01
Wall Street Target Price
11.4

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
3.44
Enterprise Value
322.6M
Enterprise Value/Revenue
3.54
Enterprise Value/Ebitda
-1.79

Technicals

Beta
2.04
50 Day MA
4.98
200 Day MA
5.36

Institutional Holdings

Bellevue Group AG

11.92%

Armistice Capital, LLC

9.97%

BlackRock Inc

9.31%

Vanguard Group Inc

6.8%

Wasatch Advisors Inc.

4.72%

Millennium Management LLC

4.24%

Discover more

Frequently Asked Questions

What is MacroGenics, Inc. share price today?

Can Indians buy MacroGenics, Inc. shares?

How can I buy MacroGenics, Inc. shares from India?

Can Fractional shares of MacroGenics, Inc. be purchased?

What are the documents required to start investing in MacroGenics, Inc. stocks?

What are today’s High and Low prices of MacroGenics, Inc.?

What are today’s traded volumes of MacroGenics, Inc.?

What is today’s market capitalisation of MacroGenics, Inc.?

What is the 52 Week High and Low Range of MacroGenics, Inc.?

How much percentage MacroGenics, Inc. is down from its 52 Week High?

How much percentage MacroGenics, Inc. is up from its 52 Week low?

What are the historical returns of MacroGenics, Inc.?

Who is the Chief Executive Officer (CEO) of MacroGenics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*